Decreased dopamine activity predicts relapse in methamphetamine abusers.
about
Pharmacotherapy for stimulant-related disordersOverlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptorsSN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulationStriatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine UsersPharmacotherapeutic agents in the treatment of methamphetamine dependence.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineConnecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivityKappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependenceStriatocortical pathway dysfunction in addiction and obesity: differences and similaritiesFunctional and structural brain changes associated with methamphetamine abuseChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.In vivo imaging of cerebral dopamine D3 receptors in alcoholism.Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence.Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.BMI modulates calorie-dependent dopamine changes in accumbens from glucose intake.Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependenceDecreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severityDopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.Dopamine challenge reveals neuroadaptive changes in marijuana abusers.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Weak ventral striatal responses to monetary outcomes predict an unwillingness to resist cigarette smoking.The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.Neurobiology of addiction: a neurocircuitry analysis.Striatal ups and downs: their roles in vulnerability to addictions in humansTolcapone suppresses ethanol intake in alcohol-preferring rats performing a novel cued access protocol.Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictorsPharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteersNeuroimaging and biomarkers in addiction treatment.Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity.A Pilot Study of Demographic and Dopaminergic Genetic Contributions to Weight Change in Kidney Transplant Recipients.Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administrationExtended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.
P2860
Q26829186-9F9B398D-7FD2-4154-8DA0-139B35999E6CQ27335194-6B5BF95F-B779-4483-9A6A-3CEE80647A8BQ28387237-B74164EC-9D38-4737-9D6D-2C763DCE18E5Q28551943-B30D8523-200E-412A-80F5-9521950A71D5Q30235058-12E7D070-EEAE-459D-AE96-BAB3B72CCDBAQ30417935-6B8F33BA-CEB2-46A4-B917-8C331DDDE880Q30419977-85E6FD84-EB0F-4029-BB9D-0EFC4E3064E4Q30422045-0DA5EA8C-C8D4-4364-B430-C6327B0C9C61Q30453617-F7A6DF0F-5BD1-4988-8BA8-F89CF11D3569Q30578245-73EDAB58-C449-434C-9B4D-9B451E3F715BQ30833169-4DB82A55-CF44-4EFE-AFB8-6A8823A01FEEQ30873118-8B88FC8D-44D8-4574-A6E0-042FEFA92404Q33620597-543C66EF-9089-4EDC-9546-4CF89D3D2792Q33671505-61D6B3A2-758B-4999-AAB8-57112E7837B7Q33700413-2AA1C9C8-BCC4-4126-9DC1-12C74A36DDCFQ33855974-FF9A9FD5-41E2-4D4C-A8D9-1366323FC680Q33989628-9122061B-0EA1-497E-A232-E03B2E0CA79CQ34002281-44C23668-E5AF-4C84-B8AD-5CCF52E07C7BQ34068906-2A227CAF-2D6D-4E19-BCA5-73142B37E336Q34082931-262EE770-B054-44D0-948E-9AC8DB223987Q34253787-55D3B69A-3BA8-4E46-86C0-D33D5253B100Q34422430-9B8F4027-3AF6-4B5B-976F-BA7F099C6DF7Q34490946-34752C01-4260-442B-AA97-1604A1172074Q34535855-93D4D48E-9CA6-49DC-911F-38275507F53AQ34554828-BFCDC80B-3C8D-4F48-8769-0DC6C0EC9897Q34660666-56120503-708B-4515-A068-E478ADEA70D7Q35174502-494C1AC5-1696-4966-9406-252F91BAE272Q35576598-A7817EB9-B25C-4EE1-A102-B8673902571FQ35580343-AB96E978-E062-4B04-A065-49E06539C145Q35594897-4E3FAA42-5E45-48D7-BFAA-27BBC3121BDFQ35634676-ED64B403-DCF5-4C70-8079-45A7B1142585Q35698391-7EE11464-7A72-49D0-9C9E-FE41AC17A811Q35787870-36D52A5A-5F2C-4317-93CF-F7675599624AQ35833732-7ED60A3E-2C8E-42D7-86C7-5C160AF55585Q35857033-588FA3EF-165D-4F65-9A7C-4DD52492752BQ35965848-B94443B4-A01A-4751-A55D-F20B6F94E5D6Q36113801-6295798B-8852-4DED-ADA1-2145BE6D9850Q36319507-7C1B22E0-9133-4725-9E02-FCE038608BF3Q36493570-4C903331-7735-462E-B46B-F528F7F60DD2Q36565693-49512521-1524-42C4-B297-0CDE2AA1A0B2
P2860
Decreased dopamine activity predicts relapse in methamphetamine abusers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@ast
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@en
type
label
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@ast
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@en
prefLabel
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@ast
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@en
P2093
P2860
P356
P1433
P1476
Decreased dopamine activity predicts relapse in methamphetamine abusers.
@en
P2093
J S Fowler
N Alia-Klein
N D Volkow
P2860
P2888
P304
P356
10.1038/MP.2011.86
P407
P577
2011-07-12T00:00:00Z